This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Ranok Therapeutics (Hangzhou) Co. Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Long Ye - Innovator in Targeted Protein Degradation
Introduction
Long Ye is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the area of targeted protein degradation. His innovative work aims to provide new therapeutic options for treating cancers and related conditions.
Latest Patents
Long Ye holds a patent for "Methods and compositions for targeted protein degradation." This patent includes compounds of Formula I and pharmaceutically acceptable salts and compositions that are useful for treating various cancers. His research is pivotal in advancing cancer treatment methodologies.
Career Highlights
Long Ye is associated with Ranok Therapeutics (Hangzhou) Co. Ltd., where he applies his expertise in developing novel therapeutic strategies. His work has garnered attention in the scientific community for its potential impact on cancer therapies.
Collaborations
He collaborates with notable colleagues, including Kevin Foley and Weiwen Ying, who contribute to his research endeavors. Their combined efforts enhance the innovation and effectiveness of the projects they undertake.
Conclusion
Long Ye's contributions to targeted protein degradation represent a significant advancement in cancer treatment. His innovative approach and collaboration with esteemed colleagues position him as a key figure in the biotechnology field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile